Menstrual Migraine

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Womens Health & Gender-Based Medicine

• Publication date

  1999-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1089/jwh.1.1999.8.919PMID 10534294
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Migraine: diagnosis and treatment].

  2001cited by this paper
• Relationship between Symptom Severity and Steroid Variation in Women with Premenstrual Syndrome: Study on Serum Pregnenolone, Pregnenoione Sulfate, k=Pregnane=3,20=Dione and 3cx-Hydroxy&u-Pregnan=20=One*

  2001cited by this paper
• Migraine and Menstruation

  2000cited by this paper
• A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine.

  1999cited by this paper
• Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.

  1998influential reference
• GnRH agonists and add‐back therapy: is there a perfect combination?

  1998cited by this paper
• Large infarcts in the middle cerebral artery territory Etiology and outcome patterns

  1998cited by this paper
• A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine

  1998cited by this paper
• Extending the Duration of Active Oral Contraceptive Pills to Manage Hormone Withdrawal Symptoms

  1997cited by this paper
• Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and "add-back" therapy.

  1997cited by this paper
• The confirmation of a biochemical marker for women's hormonal migraine: the depo-estradiol challenge test.

  1997cited by this paper
• High bone density in hyperandrogenic women: effect of gonadotropin-releasing hormone agonist alone or in conjunction with estrogen-progestin replacement.

  1996cited by this paper
• Add-back therapy in the treatment of endometriosis: the North American experience.

  1996cited by this paper
• Should add-back therapy for endometriosis be deferred for optimal results?

  1996cited by this paper
• Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.

  1996cited by this paper
• Headache epidemiology. Emphasis on migraine.

  1996cited by this paper
• Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.

  1995cited by this paper
• Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.

  1995cited by this paper
• Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.

  1995cited by this paper
• Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.

  1995cited by this paper
• Clinical Pharmacology of Estrogens: Cardiovascular Actions and Cardioprotective Benefits of Replacement Therapy in Postmenopausal Women

  1995cited by this paper
• The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group.

  1995cited by this paper
• Combination gonadotropin-releasing hormone agonist and oral contraceptive therapy improves treatment of hirsute women with ovarian hyperandrogenism.

  1995cited by this paper
• Progesterone therapy in women with complex partial and secondary generalized seizures

  1995cited by this paper
• Clinical Pharmacology of Estrogens: Cardiovascular Actions and Cardioprotective Benefits of Replacement Therapy in Postmenopausal Women

  1995cited by this paper
• Migraine Symptoms: Results of a Survey of Self‐Reported Migraineurs

  1995cited by this paper
• Sex-Hormone-Related Events in Migrainous Females. A Clinical Comparative Study Between Migraine With Aura and Migraine Without Aura

  1995cited by this paper
• Migraine Aura and Prodrome

  1995cited by this paper
• Relationship of headache to phase of the menstrual cycle among young women

  1995cited by this paper
• Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.

  1994cited by this paper
• A Prospective, Randomized Trial of Gonadotropin-Releasing Hormone Agonist Plus Estrogen-Progestin or Progestin “Add-Back” Regimens for Women With Leiomyomata Uteri

  1994cited by this paper
• Overview of diagnosis and treatment of migraine

  1994cited by this paper
• An Update on the Epidemiology of Migraine

  1994cited by this paper
• Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome.

  1994cited by this paper
• Double‐Blind Trial of Fluoxetine: Chronic Daily Headache and Migraine

  1994cited by this paper
• Long-term medical therapy for leiomyomata uteri: a prospective, randomized study of leuprolide acetate depot plus either oestrogen-progestin or progestin 'add-back' for 2 years.

  1994cited by this paper
• Perimenstrual Migraine: Effect of Estraderm TTS(r) and the Value of Contingent Negative Variation and Exteroceptive Temporalis Muscle Suppression Test

  1994cited by this paper
• Sumatriptan.

  1993cited by this paper
• The prevention of bone loss in young women treated with GnRH analogs with ‘add‐back’ estrogen therapy

  1993cited by this paper
• A Prospective, Randomized Trial of Gonadotropin‐Releasing Hormone Agonist Plus Estrogen‐Progestin or Progestin “Add‐Back” Regimens for Women With Leiomyomata Uteri

  1993cited by this paper
• Sumatriptan for the Treatment of Migraine Attacks-A Review of Controlled Clinical Trials

  1993cited by this paper
• Clinical and experimental effects of sumatriptan in humans.

  1993cited by this paper
• Treatment of Menstruation-Associated Migraine Headache With Subcutaneous Sumatriptan

  1993cited by this paper
• The Association of Menstrual Migraine with the Premenstrual Syndrome

  1993cited by this paper
• Treatment of peri‐menopausal women: potential long‐term therapy with a depot GnRH agonist combined with hormonal replacement therapy

  1992cited by this paper
• The Relationship of Ovarian Steroids, Headache Activity and Menstrual Distress: A Pilot Study With Female Migraineurs

  1992cited by this paper
• Non-Migraine Headache Across the Menstrual Cycle in Women With and Without Premenstrual Syndrome

  1992cited by this paper
• The role of GnRH analogues in the treatment of endometriosis

  1992cited by this paper
• Menstrual Migraine

  1992cited by this paper
• Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors.

  1992cited by this paper
• Estrogens, progestins, and headache

  1991influential reference
• Gonadotropin-releasing hormone and its analogues.

  1991cited by this paper
• Gonadotropin-releasing hormone and its analogues.

  1991cited by this paper
• The combination of a depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding

  1991cited by this paper
• Oral Magnesium Successfully Relieves Premenstrual Mood Changes

  1991cited by this paper
• Ineffectiveness of progesterone suppository treatment for premenstrual syndrome

  1991cited by this paper
• Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.

  1991cited by this paper
• Pharmacokinetics of estrogen

  1990cited by this paper
• The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome.

  1990cited by this paper
• Migraine and Menstruation: A Pilot Study

  1990cited by this paper
• Tamoxifen in the treatment of menstrual migraine

  1990cited by this paper
• Reversible MRI lesions in eclampsia with hydatidiform mole

  1990cited by this paper
• Repetitive Intravenous DHE in the Treatment of Refractory Headache

  1990cited by this paper
• Lasting response to ovariectomy in severe intractable premenstrual syndrome

  1990cited by this paper
• Plasma Oestrogen, Progesterone and Sex-Hormone Binding Globulin Levels in the Pathogenesis of Migraine

  1989cited by this paper
• Menstrual Migraine and Intermittent Ergonovine Therapy

  1989cited by this paper
• Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone.

  1989cited by this paper
• The treatment of premenstrual syndrome.

  1989cited by this paper
• Low Brain Magnesium in Migraine

  1989cited by this paper
• Low Brain Magnesium in Migraine

  1989cited by this paper
• Menstrual migraine: a double-blind trial of percutaneous estradiol.

  1988cited by this paper
• Induced Anovulation As Treatment Of Premenstrual Tension Syndrome: A double‐blind cross‐over study with GnRH‐agonist versus placebo

  1988cited by this paper
• GnRH agonists and antagonists. Current clinical status.

  1988cited by this paper
• Premenstrual Syndrome: Beneficial Effects of Periodic, Low‐Dose Danazol

  1987cited by this paper
• Group and Menstrual Phase Effect in Reported Headaches among College Students

  1987cited by this paper
• Efficacy of transdermal estradiol.

  1987cited by this paper
• Menstrual migraine: differential diagnosis, evaluation, and treatment.

  1987cited by this paper
• Prevention of menstrual migraine by percutaneous oestradiol.

  1986influential reference
• Prevention of migrainous headaches by tamoxifen.

  1986cited by this paper
• Premenstrual changes and changes in gonadal hormones

  1986influential reference
• Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral norethisterone: placebo controlled study.

  1986influential reference
• The Premenstrual Syndrome: Effects of “Medical Ovariectomy”

  1985cited by this paper
• PREMENSTRUAL SYNDROME

  1985cited by this paper
• A Comparison of Naproxen Sodium to Propranolol Hydrochloride and a Placebo Control for the Prophylaxis of Migraine Headache

  1985cited by this paper
• Controlled Trial of Pyridoxine in the Premenstrual Syndrome

  1985cited by this paper
• Menstrual Migraine and Other Hormonal Aspects of Migraine

  1985cited by this paper
• NO EFFECT OF VITAMIN B‐6 AGAINST PREMENSTRUAL TENSION

  1985cited by this paper
• Menstrual Migraine Headache: Results of a Controlled, Experimental, Outcome Study of Non‐drug Treatments

  1984cited by this paper
• Treatment of headache in primary care practice.

  1984cited by this paper
• Sensory neuropathy from pyridoxine abuse.

  1984cited by this paper
• Danazol and migraine.

  1984cited by this paper
• The neurobiology of vascular head pain

  1984influential reference
• Treatment of menstrual migraine by oestradiol implants.

  1983cited by this paper
• Menstrual migraine: intermittent prophylaxis with a timed-release pharmacological formulation of dihydroergotamine

  1983cited by this paper
• Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea.

  1983cited by this paper
• Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome.

  1983cited by this paper
• The premenstrual syndrome.

  1983cited by this paper
• The premenstrual syndrome. Effects of "medical ovariectomy".

  1983cited by this paper
• Hypothalamus pituitary-ovarian axis in menstrual migraine: effect of dihydroergotamine retard prophylactic treatment

  1983cited by this paper
• Binding affinity and biological activity of gonadotropin releasing hormone agonists in isolated pituitary cells.

  1982cited by this paper

• Study to Determine the Prevalence of Menstrual Migraine in Reproductive-Age Women in Saudi Arabia

  2024cites this paper
• Association between dietary caffeine intake and severe headache or migraine in US adults

  2023cites this paper
• Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology

  2019cites this paper
• Botulinum Toxin a Valuable Prophylactic Agent for Migraines and a Possible Future Option for the Prevention of Hormonal Variations-Triggered Migraines

  2019cites this paper
• Rizatriptan

  2012cites this paper
• Evaluation of Helicobacter pylori infection in patients with common migraine headache

  2011cites this paper
• Resolution of Menstrually Related Migraine Following Aggressive Treatment for Breast Cancer

  2010cites this paper
• Is iron deficiency anemia related to menstrual migraine? Post hoc analysis of an observational study evaluating clinical characteristics of patients with menstrual migraine.

  2010cites this paper
• Scheduled Short‐Term Prevention With Frovatriptan for Migraine Occurring Exclusively in Association With Menstruation

  2009cites this paper
• Behavioral management of headache triggers: Avoidance of triggers is an inadequate strategy.

  2009cites this paper
• Development of A Simple Menstrual Migraine Screening Tool for Obstetric and Gynecology Clinics: The Menstrual Migraine Assessment Tool

  2008cites this paper
• Rizatriptan for the Acute Treatment of ICHD-II Proposed Menstrual Migraine: Two Prospective, Randomized, Placebo-Controlled, Double-Blind Studies

  2007cites this paper
• Communicating with Patients about Extended-cycle and Continuous Use of Oral Contraceptives

  2007cites this paper
• The Clinical Rationale for Menses-Free Contraception

  2007cites this paper
• Efficacy of Rizatriptan for Menstrual Migraine in an Early Intervention Model: A Prospective Subgroup Analysis of the Rizatriptan TAME (Treat A Migraine Early) Studies

  2007cites this paper
• Role of the Needling per se in Acupuncture as Prophylaxis for Menstrually Related Migraine: A Randomized Placebo-Controlled Study

  2005cites this paper
• Menstrual migraine: clinical considerations in light of revised diagnostic criteria

  2005cites this paper
• The Use of Triptans in the Management of Menstrual Migraine

  2005cites this paper
• Migraine management. Focus on meeting patients' individual needs.

  2005cites this paper
• A Novel Specific Prophylaxis for Menstrual-associated Migraine

  2004cites this paper
• Rofecoxib in the Prevention of Perimenstrual Migraine: An Open‐Label Pilot Trial

  2004cites this paper
• Hereditary patterns of Belgrade university female students with migraine and nonmigraine primary headache

  2004cites this paper
• Two teenagers with headaches.

  2003cites this paper
• The etiology, biology, and evolving pathology of premenstrual syndromes.

  2003cites this paper
• Single‐Site Botulinum Toxin Type A Injection for Elimination of Migraine Trigger Points

  2003cites this paper
• Menstrual Migraine in A Representative Dutch Population Sample: Prevalence, Disability and Treatment

  2003cites this paper
• The voltage‐gated calcium channel UNC‐2 is involved in stress‐mediated regulation of tryptophan hydroxylase

  2003cites this paper
• A comparison of estrogen and two different doses of calcitonin in ovariectomized rats.

  2003cites this paper
• Prophylaxis of menstrual migraine with triptans

  2002cites this paper
• Hormonal Interventions for Menstrual Migraines

  2002cites this paper
• Surgical Treatment of Migraine Headaches

  2002cites this paper
• Prevalence of Menstrually Related Migraine and Nonmigraine Primary Headache in Female Students of Belgrade University

  2002cites this paper
• Menstrual migraine

  2001cites this paper
• Spreading depression: a review of the clinical relevance.

  2001cites this paper
• Corrugator Supercilii Muscle Resection and Migraine Headaches

  2000cites this paper